Materias dentro de su búsqueda.
Mostrando 1,181 - 1,200 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.21s Limitar resultados
  1. 1181
    “…Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites
  2. 1182
    “…Visceral leishmaniasis (VL) is a systemic disease with multifaceted clinical manifestations, including neurological signs, however, the involvement of the nervous system during VL is underestimated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice
  3. 1183
    “…The typical clinical presentations of cutaneous leishmaniasis are nodules, ulcer, nodulo-ulcerative lesions and crusted plaques. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lupoid cutaneous Leishmaniasis: A Report of Three Cases from Nonendemic Area
  4. 1184
    “…This is an important demonstration of vaccine protection against visceral leishmaniasis using a natural challenge model.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
  5. 1185
    “…BACKGROUND: Several controlled and uncontrolled studies addressing azole antifungal drugs for cutaneous and mucosal leishmaniasis have been published with inconclusive results. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis
  6. 1186
    “…BACKGROUND: Cutaneous leishmaniasis (CL) is a vector-borne disease transmitted by the bite of an infected sand fly. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cutaneous leishmaniasis in northwestern Saudi Arabia: identification of sand fly fauna and parasites
  7. 1187
    “…BACKGROUND: Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
  8. 1188
    “…Adult‐onset Still's disease (AOSD) due to visceral leishmaniasis (VL) has not been previously reported. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral leishmaniasis triggering an adult‐onset Still's disease: a unique case
  9. 1189
    “…BACKGROUND: Visceral leishmaniasis (VL) has been targeted by the WHO for elimination as a public health problem (< 1 case/10,000 people/year) in the Indian sub-continent (ISC) by 2020. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India
  10. 1190
    “…Nevertheless, to date there is no vaccine available for human leishmaniasis. We optimized and assessed in vivo the safety and immunogenicity of an innovative vaccine candidate against human visceral leishmaniasis (VL), consisting of Virus-Like Particles (VLP) loaded with three different recombinant proteins (LJL143 from Lutzomyia longipalpis saliva as the vector-derived (VD) component, and KMP11 and LeishF3+, as parasite-derived (PD) antigens) and adjuvanted with GLA-SE, a TLR4 agonist. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
  11. 1191
    “…Pentavalent antimonials, as the 1st choice for the treatment of cutaneous leishmaniasis (CL), have various side effects. Also, there are some reports of drug resistance. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy
  12. 1192
    “…Bangladesh has made significant progress towards elimination of visceral leishmaniasis, and is on track to achieve its target of less than one case per 10,000 inhabitants in each subdistrict in 2017. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sustaining visceral leishmaniasis elimination in Bangladesh – Could a policy brief help?
  13. 1193
    “…Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
  14. 1194
    “…BACKGROUND: Cutaneous leishmaniasis (CL) is one of the most important health problems in many areas of Iran. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiological Study on Cutaneous Leishmaniasis in an Endemic Area, of Qom Province, Central Iran
  15. 1195
    “…An Austrian patient with diabetes mellitus type 2 developed visceral leishmaniasis after trips to Spain and Crete, presenting with slight bicytopenia, later developing severe pancytopenia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia
  16. 1196
    “…BACKGROUND: Leishmaniasis is an extremely relevant tropical disease, with global distribution. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A decade bibliometric analysis of global research on leishmaniasis in Web of Science database
  17. 1197
    “…BACKGROUND: Visceral leishmaniasis is one of the most important vector borne diseases in the world, transmitted by sand flies. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Situational Analysis of Visceral Leishmaniasis in the Most Important Endemic Area of the Disease in Iran
  18. 1198
    “…The aims of the current study were to establish the colony of Phlebotomus sergenti Parrot (1917), the main vector of anthroponotic cutaneous leishmaniasis in old world, and to study biological parameters of this species. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Rearing and Biology of Phlebotomus sergenti, the Main Vector of Anthroponotic Cutaneous Leishmaniasis in Iran
  19. 1199
    “…More alarmingly, reports have shown that leishmaniasis is spreading to non-endemic areas of the world due to co-infection with HIV. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Leishmaniasis in Sri Lanka: spatial distribution and seasonal variations from 2009 to 2016
  20. 1200
    “…Visceral leishmaniasis (VL) is fatal if left untreated. Infected dogs are important reservoirs of the disease, and thus specific identification of infected animals is very important. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Potential application of rLc36 protein for diagnosis of canine visceral leishmaniasis
Herramientas de búsqueda: RSS